L-theanine vs GABA: two molecules, two labels
L-theanine (C7H14N2O3, CAS 3081-61-6) and GABA (C4H9NO2, CAS 56-12-2) are different molecules with different molecular weights, different certificate lines and different label names. L-theanine is chiral and needs a rotation or a chiral HPLC result; GABA is achiral, so a rotation says nothing about it. They are often sold in the same relaxation category, but there is no conversion factor and no substitution route between them.
L-theanine and GABA are two different molecules with two different labels and two different certificates; neither is a substitute for the other.
Two molecules, two identities
The names sit next to each other on a supplement shelf, and that is where the similarity ends. The two materials have different formulas, different molecular weights and different functional groups: L-theanine is a γ-glutamyl amide of ethylamine, while GABA is a four-carbon amino acid. Neither is an isomer of the other, and neither can be converted into the other by adjusting a weigh-up.
| Property | L-theanine | GABA |
|---|---|---|
| Common name | L-theanine | GABA |
| Chemical name | N-ethyl-L-glutamine | γ-aminobutyric acid |
| Formula | C7H14N2O3 | C4H9NO2 |
| CAS number | 3081-61-6 | 56-12-2 |
| Molecular weight | 174.20 | 103.12 |
| Chirality | One chiral centre; the L form is the product | Achiral; no L or D form |
| Appearance | White to off-white powder | White crystalline powder |
| Label name | L-theanine | Gamma-aminobutyric acid (GABA) |
That chirality row is the practical divide. It gives L-theanine a specific rotation and a chiral HPLC test, and it gives GABA neither. A specification written for one material cannot be copied onto the other and expected to release it.
The label has to name both, precisely
“Theanine” without the L is incomplete. The ingredient is L-theanine; D-theanine and DL-theanine are different materials, and a label that does not name the enantiomer has left the identity open. The abbreviation “GABA” is widely used, but the full name gamma-aminobutyric acid is the ingredient name, and the market's format decides how the two appear together.
A blend name does not replace the ingredient list. “Relaxation blend” or “calm complex” can be a marketing heading, but each active and its quantity still have to be declared in the form the destination requires. A label that writes “GABA (as L-theanine)” is wrong twice: the two are different ingredients, and one is not a source of the other. The same error in reverse is just as serious.
For the label reviewer, the test is simple: can each declared name be matched to its own specification, certificate and quantity? If one certificate is being used to support two declared ingredients, the file has a gap.
The arithmetic has no shared factor
Each ingredient is weighed on its own molecular weight and declared on its own line. There is no conversion factor between them: 200 mg of L-theanine is 1.148 mmol, while 200 mg of GABA is 1.939 mmol (200 ÷ 174.20 and 200 ÷ 103.12). Those figures are arithmetic, not a dose recommendation. The point is that equal milligrams are not equal molar amounts, and neither figure can be derived from the other.
Fill weight is the second constraint. A capsule holds a fixed volume; two actives at their declared doses, plus excipients and any flow aid, have to fit. A label that declares 100 mg of each needs 200 mg of actives before the first excipient, and a smaller capsule may not accommodate the blend. The formulator chooses the doses and the dosage form; the supplier cannot swap one active for the other to make the fill work.
Two certificate lines, not one
L-theanine is released on assay by HPLC, identity by HPLC retention and infrared spectrum, and specific rotation; chiral HPLC is the quantitative enantiomer test when the agreement calls for it. GABA is released on assay by HPLC and identity by infrared spectrum and retention, with no rotation line, because the molecule has no chiral centre. The two methods may share an HPLC platform, but the sample preparation, the standard and the identity evidence are different.
A certificate for L-theanine says nothing about the GABA content of a blend, and a GABA certificate says nothing about theanine. A blend needs an assay for each active, or a validated method that separates both peaks, plus the identity evidence for each. A single “total amino acids” figure is not an assay for either ingredient.
Two files, not one
In the EU, the two ingredients do not share a route. L-theanine's position depends on the source route: tea-derived material has a history of use in tea, while fermentation-derived or synthesised material has been treated as a novel food, and an application for isolated L-theanine has been under assessment. GABA has its own novel-food history and its own assessment. As of this review, the buyer's regulatory team checks the current novel-food catalogue, any authorisation and its specification, and the claims register for each ingredient separately. A file that covers one does not cover the other.
In the US, both are sold as dietary ingredients, and each needs its own basis for the intended use. Structure/function language needs substantiation and the DSHEA disclaimer, and no disease claim is open for either. A GRAS basis for a food use is ingredient-specific and use-specific, so it does not transfer from one to the other. The L-theanine compliance page sets out the documents for that file; the GABA compliance page does the same for GABA.
When the brief calls for one or the other
Start from the label and the finished product, not from the list of powders. If the label names L-theanine, the specification is L-theanine, the certificate needs the rotation and the assay, and the source route is part of the file. If the label names GABA, the specification is GABA and the identity evidence is the spectrum and the retention, with no rotation. If the brief is a blend, both certificates and a blend assay are needed.
A substitution in either direction is a change of ingredient: it needs a new specification, a new label, a new stability check and a new look at the market file. It is not a unit conversion at the balance. The L-theanine hub and the GABA hub carry the two catalog specifications; the L-theanine grades page covers the source route and the enantiomer; the methods library describes the HPLC and rotation tests; the quality page describes the release file.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation